Actually, CD26 inhibitor, also known as DPP4 inhibitor or gliptin, are a class of oral hypoglycemic drugs that antagonize the enzyme DPP4 and are approved to treat diabetes mellitus type 2 (DM-II). Here, DPP4 is linked to diabetes mellitus.